These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11274697)

  • 1. Management of glaucoma in pregnancy and lactation.
    Johnson SM; Martinez M; Freedman S
    Surv Ophthalmol; 2001; 45(5):449-54. PubMed ID: 11274697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy on intraocular pressure and retinal blood flow of a beta-blocker (timolol maleate) against the fixed association of a topical carbonic anhydrase (dorzolamide) and a beta-blocker (timolol maleate).
    Brogliatti B; Rolle T; Vizzeri GM; Cipullo D
    Acta Ophthalmol Scand Suppl; 2000; (232):47-9. PubMed ID: 11235534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of glaucoma medications during pregnancy and breastfeeding].
    Méndez-Hernández C
    Arch Soc Esp Oftalmol; 2012 Dec; 87(12):389-91. PubMed ID: 23121698
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glaucoma treatment during pregnancy and lactation].
    Bozhich M; Khentova-Senchanich P; Kontich J; Markovich V; Mar'ianovich I
    Vestn Oftalmol; 2011; 127(1):55-8. PubMed ID: 21539110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
    Gafencu O; Armegioiu M; Ionita M
    Oftalmologia; 1997; 41(1):66-8. PubMed ID: 9138500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy.
    Shin D
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S163-8. PubMed ID: 10665519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma.
    Harris A; Jonescu-Cuypers CP; Kagemann L; Nowacki EA; Garzozi H; Cole C; Martin B
    Am J Ophthalmol; 2001 Oct; 132(4):490-5. PubMed ID: 11589868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Additive effects of topical carbonic anhydrase inhibitors].
    Potocký M
    Cesk Slov Oftalmol; 2001 Jul; 57(4):250-4. PubMed ID: 11512439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid].
    Popović Suić S; Vukojević N; Cerovski B; Jukić T
    Acta Med Croatica; 2006; 60(2):101-3. PubMed ID: 16848197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dorzolamide-timolol combination versus concomitant administration of its components.
    Odberg T
    Ophthalmology; 1999 Jun; 106(6):1044-5. PubMed ID: 10366067
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A; Strahlman E; Sverrisson T; Brinchman-Hansen O; Puustjärvi T; Tipping R
    Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glaucoma: an ocular blood flow disorder?].
    Recker K
    Ophthalmologe; 2003 Feb; 100(2):2 p following 174. PubMed ID: 12650170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.